In an interview with Brenda Schulman, Director at the MPI of Biochemistry, we talked about the findings of her team's recent study and why she dedicated her life to research.
more
Researchers at the Max Planck Institute (MPI) of Biochemistry and the University of Waterloo developed a method, which could facilitate development of new "degrader" therapies that harness the power to destroy unwanted proteins.
more
MPIB researchers discovered a mechanism that recycles protein modules to enable targeted degradation of unwanted proteins and thus avoid problems in the cellular supply chain.
more
Max Planck Director Brenda Schulman receives a research grant from the European Research Council (ERC), endowed with nearly 2.1 million euros, with which she will discover crosstalk between the ubiquitin system and metabolism.
more
The 2023 Louis-Jeantet Prize for Medicine is awarded jointly to Brenda Schulman and Ivan Ðikić, for their outstanding contributions to the ubiquitin research field.
more
